HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Mio Selected Research

pembrolizumab

12/2021Efficacy and safety of immune checkpoint inhibitors in patients with non-small cell lung cancer aged 80 years or older.
7/2019Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies.
1/2018Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Mio Research Topics

Disease

58Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 06/2006
22Neoplasms (Cancer)
11/2022 - 02/2006
20Lung Neoplasms (Lung Cancer)
08/2023 - 03/2006
10Neoplasm Metastasis (Metastasis)
12/2020 - 03/2010
8Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2023 - 05/2010
7Adenocarcinoma of Lung
05/2023 - 02/2011
6Interstitial Lung Diseases (Interstitial Lung Disease)
05/2022 - 01/2007
6Infections
11/2019 - 08/2011
5COVID-19
12/2023 - 10/2020
5Adenocarcinoma
05/2023 - 01/2009
4Pneumonia (Pneumonitis)
11/2022 - 01/2018
4Communicable Diseases (Infectious Diseases)
11/2022 - 01/2019
3Fever (Fevers)
02/2024 - 09/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2024 - 08/2012
3Tuberculosis (Tuberculoses)
11/2022 - 03/2020
3Lung Diseases (Lung Disease)
01/2022 - 09/2018
3Pleural Effusion (Pleural Effusions)
01/2020 - 09/2010
3Anorexia
01/2018 - 10/2011
2Lymphangitis
02/2024 - 05/2022
2Respiratory Insufficiency (Respiratory Failure)
02/2024 - 07/2019
2Lymphoma (Lymphomas)
07/2023 - 03/2006
2Pulmonary Tuberculosis
11/2022 - 12/2016
2Liver Diseases (Liver Disease)
12/2021 - 01/2009
2Neutropenia
07/2021 - 05/2012
2Thymoma (Thymic Carcinoma)
01/2019 - 12/2013
2Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 05/2010
2Pulmonary Embolism
12/2018 - 08/2011
2Acute Kidney Injury (Acute Renal Failure)
11/2018 - 05/2014
2Malignant Mesothelioma
03/2016 - 07/2012
2Diarrhea
07/2013 - 10/2011
2Febrile Neutropenia
05/2012 - 04/2011
2Chronic Kidney Failure (Chronic Renal Failure)
04/2011 - 05/2010
1Pneumothorax
12/2023
1Pleural Empyema (Pyothorax)
06/2023
1Cognitive Dysfunction
06/2023
1Ventricular Tachycardia
01/2023
1Pain (Aches)
01/2023
1Syncope (Fainting)
01/2023
1Cardiac Arrhythmias (Arrythmia)
01/2023
1Aortitis
01/2023
1Hepatitis B
01/2023
1Melanoma (Melanoma, Malignant)
01/2022
1Ductal Carcinoma
01/2022

Drug/Important Bio-Agent (IBA)

24ErbB Receptors (EGF Receptor)IBA
02/2024 - 10/2006
17NivolumabIBA
08/2023 - 12/2016
12Immune Checkpoint InhibitorsIBA
01/2023 - 12/2016
12Gefitinib (Iressa)FDA Link
09/2012 - 01/2007
11Tyrosine Kinase InhibitorsIBA
01/2023 - 10/2008
8Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2013 - 04/2010
6Carboplatin (JM8)FDA LinkGeneric
07/2023 - 05/2012
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 03/2006
5Pemetrexed (MTA)FDA Link
04/2018 - 03/2011
4AntibodiesIBA
08/2023 - 01/2018
4osimertinibIBA
01/2023 - 01/2019
4Epidermal Growth Factor (EGF)IBA
09/2012 - 04/2010
3Biomarkers (Surrogate Marker)IBA
11/2022 - 11/2008
3Interferon-gamma (Interferon, gamma)IBA
11/2022 - 11/2019
3pembrolizumabIBA
12/2021 - 01/2018
3Anaplastic Lymphoma KinaseIBA
01/2021 - 01/2017
3GemcitabineFDA Link
03/2016 - 02/2011
3Irinotecan (Camptosar)FDA LinkGeneric
12/2012 - 04/2011
3OSI-420IBA
09/2011 - 05/2010
2IpilimumabIBA
08/2023 - 05/2022
2SolutionsIBA
03/2022 - 01/2020
2Amino AcidsFDA Link
09/2018 - 06/2009
2Bevacizumab (Avastin)FDA Link
04/2018 - 08/2011
2Vinorelbine (Navelbine)FDA LinkGeneric
01/2018 - 05/2012
2Docetaxel (Taxotere)FDA Link
12/2013 - 10/2010
2nedaplatinIBA
12/2013 - 02/2011
2amrubicinIBA
12/2012 - 05/2010
2Insulin-Like Growth Factor Binding Protein 3IBA
09/2012 - 10/2011
2Insulin-Like PeptidesIBA
09/2012 - 10/2011
2PlatinumIBA
08/2012 - 11/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2012 - 11/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2011 - 10/2009
2Codon (Codons)IBA
11/2010 - 06/2009
2Phosphotransferases (Kinase)IBA
11/2010 - 04/2010
1AfatinibIBA
02/2024
1Anti-Bacterial Agents (Antibiotics)IBA
02/2024
1Paclitaxel (Taxol)FDA LinkGeneric
07/2023
1molnupiravirIBA
06/2023
1sotorasibIBA
05/2023
1pegfilgrastim (Neulasta)FDA Link
01/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2023
1Etoposide (VP 16)FDA LinkGeneric
01/2023
1durvalumabIBA
01/2023
1Carcinoembryonic AntigenIBA
05/2022
1Immunoglobulin G (IgG)IBA
01/2022

Therapy/Procedure

18Drug Therapy (Chemotherapy)
11/2023 - 09/2010
15Therapeutics
11/2022 - 06/2006
13Immunotherapy
08/2023 - 12/2016
5Chemoradiotherapy
07/2023 - 06/2006
4Radiotherapy
01/2019 - 03/2006
3Retreatment
01/2020 - 01/2018
2Activities of Daily Living (ADL)
06/2023 - 01/2021
2Catheters
06/2023 - 08/2011
2Artificial Respiration (Mechanical Ventilation)
01/2019 - 05/2014
2Renal Dialysis (Hemodialysis)
04/2011 - 05/2010
1Peritoneal Dialysis
02/2024
1Duration of Therapy
12/2023